Alamar Biosciences Closes $80 Million Series B
FREMONT -- Alamar Biosciences, Inc., a precision proteomics company that brings both ultra-high sensitivity and…
Venture Capital
Venture Capital
Checkr Checks In With $250 Million Series E
SAN FRANCISCO – Checkr, a leading a provider of employee background checks, has raised $250 million in…